Advanced

Wilms' tumor gene 1 protein represses the expression of the tumor suppressor interferon regulatory factor 8 in human hematopoietic progenitors and in leukemic cells.

Vidovic, Karina LU ; Svensson, Emelie LU ; Nilsson, Björn LU ; Thuresson, Britt LU ; Olofsson, Tor LU ; Lennartsson, Andreas LU and Gullberg, Urban LU (2010) In Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 24(5). p.992-1000
Abstract
Wilms' tumor gene 1 (WT1) is a transcription factor involved in developmental processes. In adult hematopoiesis, only a small portion of early progenitor cells express WT1, whereas most leukemias show persistently high levels, suggesting an oncogenic role. We have previously characterized oncogenic BCR/ABL1 tyrosine kinase signaling pathways for increased WT1 expression. In this study, we show that overexpression of BCR/ABL1 in CD34+ progenitor cells leads to reduced expression of interferon regulatory factor 8 (IRF8), in addition to increased WT1 expression. Interestingly, IRF8 is known as a tumor suppressor in some leukemias and we investigated whether WT1 might repress IRF8 expression. When analyzed in four leukemia mRNA expression data... (More)
Wilms' tumor gene 1 (WT1) is a transcription factor involved in developmental processes. In adult hematopoiesis, only a small portion of early progenitor cells express WT1, whereas most leukemias show persistently high levels, suggesting an oncogenic role. We have previously characterized oncogenic BCR/ABL1 tyrosine kinase signaling pathways for increased WT1 expression. In this study, we show that overexpression of BCR/ABL1 in CD34+ progenitor cells leads to reduced expression of interferon regulatory factor 8 (IRF8), in addition to increased WT1 expression. Interestingly, IRF8 is known as a tumor suppressor in some leukemias and we investigated whether WT1 might repress IRF8 expression. When analyzed in four leukemia mRNA expression data sets, WT1 and IRF8 were anticorrelated. Upon overexpression in CD34+ progenitors, as well as in U937 cells, WT1 strongly downregulated IRF8 expression. All four major WT1 splice variants induced repression, but not the zinc-finger-deleted WT1 mutant, indicating dependence on DNA binding. A reporter construct with the IRF8 promoter was repressed by WT1, dependent on a putative WT1-response element. Binding of WT1 to the IRF8 promoter was demonstrated by chromatin immunoprecipitation. Our results identify IRF8 as a direct target gene for WT1 and provide a possible mechanism for oncogenic effects of WT1 in leukemia.Leukemia advance online publication, 18 March 2010; doi:10.1038/leu.2010.33. (Less)
Please use this url to cite or link to this publication:
author
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K
volume
24
issue
5
pages
992 - 1000
publisher
Nature Publishing Group
external identifiers
  • wos:000277591500011
  • pmid:20237505
  • scopus:77952389676
ISSN
1476-5551
DOI
10.1038/leu.2010.33
language
English
LU publication?
yes
id
f1bb8fa3-911b-4052-9059-24ebf985bd17 (old id 1581951)
alternative location
http://www.ncbi.nlm.nih.gov/pubmed/20237505?dopt=Abstract
date added to LUP
2010-04-08 14:30:19
date last changed
2018-05-29 10:43:41
@article{f1bb8fa3-911b-4052-9059-24ebf985bd17,
  abstract     = {Wilms' tumor gene 1 (WT1) is a transcription factor involved in developmental processes. In adult hematopoiesis, only a small portion of early progenitor cells express WT1, whereas most leukemias show persistently high levels, suggesting an oncogenic role. We have previously characterized oncogenic BCR/ABL1 tyrosine kinase signaling pathways for increased WT1 expression. In this study, we show that overexpression of BCR/ABL1 in CD34+ progenitor cells leads to reduced expression of interferon regulatory factor 8 (IRF8), in addition to increased WT1 expression. Interestingly, IRF8 is known as a tumor suppressor in some leukemias and we investigated whether WT1 might repress IRF8 expression. When analyzed in four leukemia mRNA expression data sets, WT1 and IRF8 were anticorrelated. Upon overexpression in CD34+ progenitors, as well as in U937 cells, WT1 strongly downregulated IRF8 expression. All four major WT1 splice variants induced repression, but not the zinc-finger-deleted WT1 mutant, indicating dependence on DNA binding. A reporter construct with the IRF8 promoter was repressed by WT1, dependent on a putative WT1-response element. Binding of WT1 to the IRF8 promoter was demonstrated by chromatin immunoprecipitation. Our results identify IRF8 as a direct target gene for WT1 and provide a possible mechanism for oncogenic effects of WT1 in leukemia.Leukemia advance online publication, 18 March 2010; doi:10.1038/leu.2010.33.},
  author       = {Vidovic, Karina and Svensson, Emelie and Nilsson, Björn and Thuresson, Britt and Olofsson, Tor and Lennartsson, Andreas and Gullberg, Urban},
  issn         = {1476-5551},
  language     = {eng},
  number       = {5},
  pages        = {992--1000},
  publisher    = {Nature Publishing Group},
  series       = {Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K},
  title        = {Wilms' tumor gene 1 protein represses the expression of the tumor suppressor interferon regulatory factor 8 in human hematopoietic progenitors and in leukemic cells.},
  url          = {http://dx.doi.org/10.1038/leu.2010.33},
  volume       = {24},
  year         = {2010},
}